Introduction The relationship between the United States and the World Health Organization (WHO) stands as one of...
Azzam Bilal Chamdy
Introduction On 6 March 2025, at the prestigious EIB Group Forum in Luxembourg, a pivotal development in...
The journey through a breast cancer diagnosis is profoundly personal, often marked by challenges that test the...
Note: Originally published on Nov. 12, 2025, this resource is updated as needed, most recently on August...
For decades, the primary metric of success in the fight against breast cancer has been survival. As...
The landscape of metastatic HER2-positive breast cancer is undergoing a seismic shift. For over a decade, the...
WASHINGTON, D.C. — As the heat of summer begins to wane, the national advocacy landscape is bracing...
The landscape of breast cancer treatment is undergoing a seismic shift. As therapeutic modalities move toward highly...
The global landscape of pharmaceutical innovation and clinical research is undergoing a profound transformation, with the Asia-Pacific...
In the high-stakes world of infectious disease drug development, the “holy grail” is a universal treatment—a single...
